1. Restarting and restoring research across the UK and across all disease areas.

2. Transforming the UK clinical research environment with investment to increase
levels of research beyond pre-COVID levels by:

a. Optimising the processes for setting up and running clinical trials

b. Building a workforce fit for the future with opportunities for all to be involved in research

c. Harnessing the UK’s health data to support the efficient design, feasibility, recruitment and conduct of the full range of clinical trials

d. Driving continuing high standards for transparency

e. Creating a regulatory environment which supports innovation in life sciences

3. Ensuring that all patients have the opportunity to be involved and engaged with research

4. Making research and innovation central to the UK’s trade strategy